In vivo purging of bone marrow in children with poor-risk neuroblastoma for marrow collection and autologous bone marrow transplantation.

Saarinen, U M; Wikström, S; Mäkipernaa, A; Lanning, M; Perkkiö, M; Hovi, L; Rapola, J; Sariola, H

Saarinen, U M; Wikström, S; Mäkipernaa, A; Lanning, M; Perkkiö, M; Hovi, L; Rapola, J; Sariola, H.

Affiliation

Saarinen UM; Division of Pediatric Hematology/Oncology, Children's Hospital, University of Helsinki, Finland.

J Clin Oncol ; 14(10): 2791-802, 1996 Oct.

Article in En | MEDLINE | ID: mdl-8874341

Subject(s)

Bone Marrow Examination; Bone Marrow Purging/methods; Bone Marrow Transplantation; Neuroblastoma/therapy; Transplantation Conditioning; Adolescent; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bone Marrow/pathology; Child; Child, Preschool; Drug Resistance, Neoplasm; Feasibility Studies; Female; Fluorescent Antibody Technique, Indirect; Graft Survival; Humans; Infant; Male; Neuroblastoma/pathology; Prospective Studies; Sensitivity and Specificity; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Examination / Bone Marrow Transplantation / Bone Marrow Purging / Transplantation Conditioning / Neuroblastoma Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Clin Oncol Year: 1996 Type: Article Affiliation country: Finland

Search on Google

XML

PubMed Links